Literature DB >> 836998

Production of prostaglandins by the pseudopregnant rat uterus, in vitro, and the effect of tamoxifen with the identification of 6-keto-prostaglandin F1alpha as a major product.

L Fenwick, R L Jones, B Naylor, N L Poyser, N H Wilson.   

Abstract

1 Prostaglandin production by rat uterus homogenates has been studied, in vitro, on days 2 to 13 of pseudopregnancy. 2 The highest production of prostaglandins occurred on day 5. 3 The amounts of prostaglandins F and D formed were higher than the amounts of prostaglandin E on every day studied. 4 The ratios of prostglandins F and D to prostaglandin E produced steadily decreased up to day 6. It then increased with the highest values occurring between days 10 and 13, 5 Progesterone levels in peripheral plasma increased rapidly from days 2 to 5, remained high up to day 9, then steadily decreased between days 10 and 13. 6 The anti-oestrogenic drug, tamoxifen administered on day 2, significantly inhibited the increase of prostaglandin production which occurred on day 5. Prostaglandin E production was inhibited more than the production of prostaglandins F and D. 7 Analysis of the uterine extracts by gas chromatography and mass spectrometry showed prostaglandin F2alpha, F1alpha (in trace amounts), E2 and D2 to be present. 8 The major product detected was 6-keto-prostaglandin F1alpha. Its identification forms an addendum to the paper. 9 Also present as a major product was 6(9)-oxy-11,15-dihydroxyprosta-7,13-dienoic acid.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 836998      PMCID: PMC1667701          DOI: 10.1111/j.1476-5381.1977.tb06993.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.

Authors:  R Welschen; P Osman; J Dullaart; W J de Greef; J T Uilenbroek; F H de Jong
Journal:  J Endocrinol       Date:  1975-01       Impact factor: 4.286

2.  A new prostaglandin metabolite of arachidonic acid. Formation of 6-keto-PGF1alpha by the rat stomach.

Authors:  C Pace-Asciak
Journal:  Experientia       Date:  1976-03-15

3.  Estrogen-directed synthesis of specific prostaglandins in uterus.

Authors:  E A Ham; V J Cirillo; M E Zanetti; F A Kuehl
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

4.  Peripheral plasma levels of E and F series prostaglandins during pseudopregnancy in the rat.

Authors:  S K Saksena; D T Watson; I F Lau; A A Shaikh
Journal:  Prostaglandins       Date:  1974-03-25

5.  Ovarian secretion of oestradiol, oestrone, 20-dihydroprogesterone and progesterone during the oestrous cycle of the guinea-pig.

Authors:  H S Joshi; D J Watson; A P Labhsetwar
Journal:  J Reprod Fertil       Date:  1973-10

6.  A simple device for analogue recording of the abundance of selected ions from a combined gas chromatograph-mass spectrometer.

Authors:  R W Kelly
Journal:  J Chromatogr       Date:  1972-09-06

7.  The release of prostaglandins and progestin into the utero-ovarian venous blood of guinea-pigs during the oestrous cycle and following oestrogen treatment.

Authors:  F R Blatchley; B T Donovan; E W Horton; N L Poyser
Journal:  J Physiol       Date:  1972-05       Impact factor: 5.182

8.  Production of prostaglandins by the guinea-pig uterus.

Authors:  N L Poyser
Journal:  J Endocrinol       Date:  1972-07       Impact factor: 4.286

9.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

10.  Effect of decidual tissue on the uterine production of prostaglandins in pseudopregnant rats.

Authors:  V D Castracane; A A Shaikh
Journal:  J Reprod Fertil       Date:  1976-01
View more
  8 in total

1.  Identification of thromboxane B2 in guinea-pig uterine homogenates.

Authors:  N L Poyser
Journal:  Experientia       Date:  1977-12-15

Review 2.  Nongenomic action of steroids in myometrial contractility.

Authors:  M Perusquía
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

Review 3.  Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

4.  Prostaglandins, thromboxanes and the pregnant rat uterus at term.

Authors:  C A Phillips; N L Poyser
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

5.  Effects of prostaglandins E2 and I2 on human lymphocyte transformation in the presence and absence of inhibitors of prostaglandin biosynthesis.

Authors:  D Gordon; D C Henderson; J Westwick
Journal:  Br J Pharmacol       Date:  1979-09       Impact factor: 8.739

6.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

7.  Contribution to the pathogenesis of dysmenorrhea.

Authors:  H P Zahradnik; M Breckwoldt
Journal:  Arch Gynecol       Date:  1984

8.  Suppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer.

Authors:  A L Harris; M D Mitchell; I E Smith; T J Powles
Journal:  Br J Cancer       Date:  1983-10       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.